Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Upgrade
UBS upgrades Dentsply Sirona to Buy, says issues 'largely transitory' » 16:41
06/01/22
06/01
16:41
06/01/22
16:41
XRAY

Dentsply Sirona

$39.03 /

-0.54 (-1.36%)

UBS analyst Kevin…

UBS analyst Kevin Caliendo upgraded Dentsply Sirona to Buy from Neutral with a price target of $47, down from $58, implying 18% upside potential. Following "extensive" channel checks, the analyst believes the concerns coming out of the company's Q1 earnings, including increased inventories, lower margins, COVID and management uncertainty are "explainable and largely transitory." His analysis of Dentsply's current inventory headwind suggests that the issue is "meaningfully less impactful than 2018, yet the stock is down near 2018 multiples." The analyst also expects the company's margins to stabilize and cash flow to improve going forward. Caliendo views Dentsply Sirona's valuation as "compelling" at current share levels.

ShowHide Related Items >><<
XRAY Dentsply Sirona
$39.03 /

-0.54 (-1.36%)

XRAY Dentsply Sirona
$39.03 /

-0.54 (-1.36%)

06/01/22 UBS
Dentsply Sirona upgraded to Buy from Neutral at UBS
05/11/22 Barrington
Dentsply Sirona price target lowered to $51 from $53 at Barrington
05/10/22 Piper Sandler
Piper trims Dentsply Sirona target, says recovery could be 'long and costly'
04/22/22 H.C. Wainwright
Dentsply Sirona price target lowered to $48 from $58 at H.C. Wainwright
XRAY Dentsply Sirona
$39.03 /

-0.54 (-1.36%)

XRAY Dentsply Sirona
$39.03 /

-0.54 (-1.36%)

XRAY Dentsply Sirona
$39.03 /

-0.54 (-1.36%)

Upgrade
Dentsply Sirona upgraded to Buy from Neutral at UBS » 16:33
06/01/22
06/01
16:33
06/01/22
16:33
XRAY

Dentsply Sirona

$39.03 /

-0.54 (-1.36%)

UBS analyst Kevin…

UBS analyst Kevin Caliendo upgraded Dentsply Sirona to Buy from Neutral with a price target of $47, down from $58.

ShowHide Related Items >><<
XRAY Dentsply Sirona
$39.03 /

-0.54 (-1.36%)

XRAY Dentsply Sirona
$39.03 /

-0.54 (-1.36%)

05/11/22 Barrington
Dentsply Sirona price target lowered to $51 from $53 at Barrington
05/10/22 Piper Sandler
Piper trims Dentsply Sirona target, says recovery could be 'long and costly'
04/22/22 H.C. Wainwright
Dentsply Sirona price target lowered to $48 from $58 at H.C. Wainwright
04/20/22 Barrington
Dentsply Sirona price target lowered to $53 from $72 at Barrington
XRAY Dentsply Sirona
$39.03 /

-0.54 (-1.36%)

XRAY Dentsply Sirona
$39.03 /

-0.54 (-1.36%)

XRAY Dentsply Sirona
$39.03 /

-0.54 (-1.36%)

Hot Stocks
Dentsply Sirona receives notice of filing delinquency from Nasdaq » 08:15
05/18/22
05/18
08:15
05/18/22
08:15
XRAY

Dentsply Sirona

$38.95 /

+0.64 (+1.67%)

DENTSPLY SIRONA received…

DENTSPLY SIRONA received written notification from The NASDAQ Stock Market on May 12, 2022 that the Company is no longer in compliance with the Nasdaq Listing Rules since the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2022. Nasdaq Listing Rule 5250(c)(1) requires Nasdaq-listed companies to timely file all periodic reports. This notice from Nasdaq has no immediate effect on the listing of the Company's common stock on the Nasdaq Global Market. As previously reported by the Company in its Notification of Late Filing on Form 12b-25, filed with the Securities and Exchange Commission on May 10, 2022, the Company was unable to file the 10-Q for the period ended March 31, 2022 within the prescribed period because the Company's Audit and Finance Committee, together with independent outside counsel, is conducting an investigation concerning the Company's use of incentives to sell products to distributors in the third and fourth quarters of 2021, whether those incentives were appropriately accounted for and whether the impact of those sales was adequately disclosed in the Company's periodic reports filed with the Commission. The Company expects to file the Quarterly Report as soon as practicable.

ShowHide Related Items >><<
XRAY Dentsply Sirona
$38.95 /

+0.64 (+1.67%)

XRAY Dentsply Sirona
$38.95 /

+0.64 (+1.67%)

05/11/22 Barrington
Dentsply Sirona price target lowered to $51 from $53 at Barrington
05/10/22 Piper Sandler
Piper trims Dentsply Sirona target, says recovery could be 'long and costly'
04/22/22 H.C. Wainwright
Dentsply Sirona price target lowered to $48 from $58 at H.C. Wainwright
04/20/22 Barrington
Dentsply Sirona price target lowered to $53 from $72 at Barrington
XRAY Dentsply Sirona
$38.95 /

+0.64 (+1.67%)

XRAY Dentsply Sirona
$38.95 /

+0.64 (+1.67%)

XRAY Dentsply Sirona
$38.95 /

+0.64 (+1.67%)

Recommendations
Dentsply Sirona price target lowered to $51 from $53 at Barrington » 09:36
05/11/22
05/11
09:36
05/11/22
09:36
XRAY

Dentsply Sirona

$36.37 /

-2.91 (-7.41%)

Barrington analyst…

Barrington analyst Michael Petusky lowered the firm's price target on Dentsply Sirona to $51 from $53 and keeps an Outperform rating on the shares. Though he admits there is "noise" and uncertainty after the company lowered its FY22 guidance and said it now expects to generate 2-3% organic revenue growth, Petusky said he suspects that investors who purchase shares below $40 "will look very smart three years from now," though he concedes he "cannot prove it today."

ShowHide Related Items >><<
XRAY Dentsply Sirona
$36.37 /

-2.91 (-7.41%)

XRAY Dentsply Sirona
$36.37 /

-2.91 (-7.41%)

05/10/22 Piper Sandler
Piper trims Dentsply Sirona target, says recovery could be 'long and costly'
04/22/22 H.C. Wainwright
Dentsply Sirona price target lowered to $48 from $58 at H.C. Wainwright
04/20/22 Barrington
Dentsply Sirona price target lowered to $53 from $72 at Barrington
04/19/22 Piper Sandler
Dentsply Sirona downgraded to Neutral from Overweight at Piper Sandler
XRAY Dentsply Sirona
$36.37 /

-2.91 (-7.41%)

XRAY Dentsply Sirona
$36.37 /

-2.91 (-7.41%)

XRAY Dentsply Sirona
$36.37 /

-2.91 (-7.41%)

Hot Stocks
Moderna CFO Jorge Gomez departs, recently retired David Meline to continue role » 08:26
05/11/22
05/11
08:26
05/11/22
08:26
MRNA

Moderna

$132.32 /

-3.42 (-2.52%)

, XRAY

Dentsply Sirona

$36.37 /

-2.91 (-7.41%)

Moderna (MRNA) announced…

Moderna (MRNA) announced that its recently appointed CFO Jorge Gomez, has departed the Company, effective immediately. The announcement follows the May 10 public disclosure by Mr. Gomez's former employer, Dentsply Sirona (XRAY) of an ongoing internal investigation into certain matters, including financial reporting. Moderna's recently retired CFO David Meline, will continue in his role of CFO as of May 11 while Moderna reopens its search for a new CFO.

ShowHide Related Items >><<
XRAY Dentsply Sirona
$36.37 /

-2.91 (-7.41%)

MRNA Moderna
$132.32 /

-3.42 (-2.52%)

MRNA Moderna
$132.32 /

-3.42 (-2.52%)

04/20/22 Piper Sandler
Piper says 'do not be fooled,' Arcturus Phase 3 shows strong vaccine efficacy
04/19/22 Piper Sandler
Moderna's bivalent booster improves titers against omicron, says Piper Sandler
04/11/22 Piper Sandler
CFO leaves Dentsply for Moderna, outside replacement more likely, says Piper
03/25/22 Piper Sandler
Moderna pipeline growing and 'de-risked,' says Piper Sandler
XRAY Dentsply Sirona
$36.37 /

-2.91 (-7.41%)

05/10/22 Piper Sandler
Piper trims Dentsply Sirona target, says recovery could be 'long and costly'
04/22/22 H.C. Wainwright
Dentsply Sirona price target lowered to $48 from $58 at H.C. Wainwright
04/20/22 Barrington
Dentsply Sirona price target lowered to $53 from $72 at Barrington
04/19/22 Piper Sandler
Dentsply Sirona downgraded to Neutral from Overweight at Piper Sandler
XRAY Dentsply Sirona
$36.37 /

-2.91 (-7.41%)

MRNA Moderna
$132.32 /

-3.42 (-2.52%)

MRNA Moderna
$132.32 /

-3.42 (-2.52%)

XRAY Dentsply Sirona
$36.37 /

-2.91 (-7.41%)

MRNA Moderna
$132.32 /

-3.42 (-2.52%)

XRAY Dentsply Sirona
$36.37 /

-2.91 (-7.41%)

MRNA Moderna
$132.32 /

-3.42 (-2.52%)

Recommendations
Piper trims Dentsply Sirona target, says recovery could be 'long and costly' » 15:28
05/10/22
05/10
15:28
05/10/22
15:28
XRAY

Dentsply Sirona

$36.52 /

-2.76 (-7.03%)

Piper Sandler analyst…

Piper Sandler analyst Jason Bednar lowered the firm's price target on Dentsply Sirona to $41 from $46 and keeps a Neutral rating on the shares after the company reported Q1 revenue and EPS consistent with last month's preliminary results but reinstated guidance that shows meaningful near-term profitability pressures. In addition, the investigation from the board's audit committee into channel stuffing that may have aided in hitting comp targets is an incremental concern that adds to the risks, contends Bednar, who thinks Street estimates "may now move to a more defensible level" for 2022 and 2023. While the current valuation could provide a floor, he sees a lack of near-term catalysts and thinks the "recovery path could be long and costly," Bednar added.

ShowHide Related Items >><<
XRAY Dentsply Sirona
$36.52 /

-2.76 (-7.03%)

XRAY Dentsply Sirona
$36.52 /

-2.76 (-7.03%)

04/22/22 H.C. Wainwright
Dentsply Sirona price target lowered to $48 from $58 at H.C. Wainwright
04/20/22 Barrington
Dentsply Sirona price target lowered to $53 from $72 at Barrington
04/19/22 Piper Sandler
Dentsply Sirona downgraded to Neutral from Overweight at Piper Sandler
04/19/22 BofA
BofA downgrades Dentsply Sirona, says 'too much unknown' after pre-announcement
XRAY Dentsply Sirona
$36.52 /

-2.76 (-7.03%)

XRAY Dentsply Sirona
$36.52 /

-2.76 (-7.03%)

XRAY Dentsply Sirona
$36.52 /

-2.76 (-7.03%)

On The Fly
Fly Intel: Pre-market Movers » 09:06
05/10/22
05/10
09:06
05/10/22
09:06
BHVN

Biohaven Pharmaceutical

$83.34 /

-6.81 (-7.55%)

, PFE

Pfizer

$48.68 /

-0.385 (-0.78%)

, PTON

Peloton

$14.13 /

-1.59 (-10.12%)

, UPST

Upstart

$77.01 /

-6.81 (-8.12%)

, GDRX

GoodRx

$10.75 /

-2.01 (-15.76%)

, ATER

Aterian

$4.00 /

-0.33 (-7.63%)

, CARG

CarGurus

$29.82 /

-1.89 (-5.96%)

, ALV

Autoliv

$70.57 /

-1.8 (-2.49%)

, XRAY

Dentsply Sirona

$39.26 /

-1.335 (-3.29%)

, SWAV

ShockWave Medical

$115.98 /

-21.305 (-15.52%)

, PLUG

Plug Power

$16.64 /

-2.76 (-14.23%)

, LPSN

LivePerson

$16.27 /

-2.55 (-13.55%)

, CLOV

Clover Health

$2.42 /

-0.27 (-10.04%)

Check out this morning's…

ShowHide Related Items >><<
XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

UPST Upstart
$77.01 /

-6.81 (-8.12%)

SWAV ShockWave Medical
$115.98 /

-21.305 (-15.52%)

PTON Peloton
$14.13 /

-1.59 (-10.12%)

PLUG Plug Power
$16.64 /

-2.76 (-14.23%)

PFE Pfizer
$48.68 /

-0.385 (-0.78%)

LPSN LivePerson
$16.27 /

-2.55 (-13.55%)

GDRX GoodRx
$10.75 /

-2.01 (-15.76%)

CLOV Clover Health
$2.42 /

-0.27 (-10.04%)

CARG CarGurus
$29.82 /

-1.89 (-5.96%)

BHVN Biohaven Pharmaceutical
$83.34 /

-6.81 (-7.55%)

ATER Aterian
$4.00 /

-0.33 (-7.63%)

ALV Autoliv
$70.57 /

-1.8 (-2.49%)

BHVN Biohaven Pharmaceutical
$83.34 /

-6.81 (-7.55%)

05/02/22 Piper Sandler
Piper sees 'outright misinformation' on Biohaven, says buy shares
04/22/22 Piper Sandler
Biohaven widening lead over AbbVie in migraine, says Piper Sandler
03/03/22 Mizuho
Biohaven Pharmaceutical price target raised to $154 from $144 at Mizuho
02/25/22 Piper Sandler
Biohaven continues execution story with two deals, says Piper Sandler
PFE Pfizer
$48.68 /

-0.385 (-0.78%)

05/05/22 Stifel
Stifel keeps Buy rating on Arvinas, lowers price target to $82
05/04/22 Wells Fargo
Pfizer price target lowered to $55 from $60 at Wells Fargo
05/03/22 RBC Capital
Clinical hold being lifted a 'clear positive' for Sangamo, says RBC Capital
04/20/22 Piper Sandler
Piper says 'do not be fooled,' Arcturus Phase 3 shows strong vaccine efficacy
PTON Peloton
$14.13 /

-1.59 (-10.12%)

04/19/22 Citi
Peloton assumed with Buy from Neutral at Citi
04/08/22 Morgan Stanley
Peloton may top 3M Connected Fitness subscribers in Q3, says Morgan Stanley
03/31/22 Evercore ISI
Peloton shares may stay range-bound in near-to-mid-term, says Evercore ISI
03/14/22 Bernstein
Peloton initiated with an Outperform at Bernstein
UPST Upstart
$77.01 /

-6.81 (-8.12%)

05/10/22 Goldman Sachs
Upstart downgraded to Neutral from Buy at Goldman Sachs
05/10/22 Wedbush
Upstart price target lowered to $35 from $70 at Wedbush
05/10/22 Stephens
Upstart downgraded to Underweight from Equal Weight at Stephens
05/10/22 Stephens
Affirm downgraded to Underweight at Stephens after Upstart earnings
GDRX GoodRx
$10.75 /

-2.01 (-15.76%)

05/10/22 Raymond James
GoodRx downgraded to Market Perform from Outperform at Raymond James
05/10/22 RBC Capital
RBC Capital cuts GoodRx to Sector Perform on reduced visibility, pulled guidance
05/10/22 Barclays
GoodRx price target lowered to $15 from $28 at Barclays
05/10/22 SVB Securities
GoodRx downgraded to Market Perform from Outperform at SVB Leerink
ATER Aterian
$4.00 /

-0.33 (-7.63%)

03/11/22 Alliance Global Partners
Aterian price target lowered to $4.50 from $9 at Alliance Global Partners
03/09/22 BTIG
Aterian price target lowered to $5 from $9 at BTIG
03/09/22 DA Davidson
Aterian price target lowered to $7 from $14 at DA Davidson
02/11/22 Alliance Global Partners
Aterian price target lowered to $9 from $13 at Alliance Global Partners
CARG CarGurus
$29.82 /

-1.89 (-5.96%)

05/10/22 Benchmark
CarGurus price target lowered to $50 from $63 at Benchmark
05/10/22 BTIG
CarGurus price target lowered to $43 from $49 at BTIG
05/10/22 Raymond James
CarGurus price target lowered to $34 from $52 at Raymond James
05/10/22 Oppenheimer
CarGurus price target lowered to $38 from $45 at Oppenheimer
ALV Autoliv
$70.57 /

-1.8 (-2.49%)

05/09/22 UBS
Autoliv upgraded to Buy on attractive entry point at UBS
05/09/22 UBS
Autoliv upgraded to Buy from Neutral at UBS
04/26/22 Deutsche Bank
Autoliv price target lowered to $86 from $96 at Deutsche Bank
04/25/22 RBC Capital
Autoliv price target lowered to $97 from $116 at RBC Capital
XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

04/22/22 H.C. Wainwright
Dentsply Sirona price target lowered to $48 from $58 at H.C. Wainwright
04/20/22 Barrington
Dentsply Sirona price target lowered to $53 from $72 at Barrington
04/19/22 Piper Sandler
Dentsply Sirona downgraded to Neutral from Overweight at Piper Sandler
04/19/22 BofA
BofA downgrades Dentsply Sirona, says 'too much unknown' after pre-announcement
SWAV ShockWave Medical
$115.98 /

-21.305 (-15.52%)

05/10/22 Canaccord
ShockWave Medical price target lowered to $190 from $221 at Canaccord
05/10/22 Wells Fargo
ShockWave Medical price target lowered to $176 from $235 at Wells Fargo
05/10/22 Piper Sandler
ShockWave pullback an opportunity after 'strong' Q1, says Piper Sandler
04/05/22 Wolfe Research
ShockWave Medical initiated with an Outperform at Wolfe Research
PLUG Plug Power
$16.64 /

-2.76 (-14.23%)

05/10/22 Craig-Hallum
Plug Power price target lowered to $31 from $49 at Craig-Hallum
05/10/22 Susquehanna
Plug Power price target lowered to $30 from $33 at Susquehanna
05/02/22 Truist
Plug Power assumed with a Hold at Truist
04/26/22 KeyBanc
KeyBanc says Axios report positive for Plug Power, other fuel cell names
LPSN LivePerson
$16.27 /

-2.55 (-13.55%)

05/10/22 B. Riley
LivePerson price target lowered to $19 from $23 at B. Riley
05/10/22 Mizuho
LivePerson price target lowered to $18 from $20 at Mizuho
05/10/22 Roth Capital
LivePerson upgraded to Buy from Neutral at Roth Capital
04/08/22 Loop Capital
LivePerson price target raised to $30 from $23 at Loop Capital
CLOV Clover Health
$2.42 /

-0.27 (-10.04%)

02/24/22 Canaccord
Clover Health price target raised to $7 from $6 at Canaccord
02/17/22 Citi
Citi opens 'negative catalyst watches' in health care services
02/02/22 Cowen
Clover Health upgraded to Market Perform from Underperform at Cowen
01/19/22 SVB Securities
Clover Health initiated with a Market Perform at SVB Leerink
XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

UPST Upstart
$77.01 /

-6.81 (-8.12%)

SWAV ShockWave Medical
$115.98 /

-21.305 (-15.52%)

PTON Peloton
$14.13 /

-1.59 (-10.12%)

PLUG Plug Power
$16.64 /

-2.76 (-14.23%)

PFE Pfizer
$48.68 /

-0.385 (-0.78%)

LPSN LivePerson
$16.27 /

-2.55 (-13.55%)

GDRX GoodRx
$10.75 /

-2.01 (-15.76%)

CLOV Clover Health
$2.42 /

-0.27 (-10.04%)

CARG CarGurus
$29.82 /

-1.89 (-5.96%)

BHVN Biohaven Pharmaceutical
$83.34 /

-6.81 (-7.55%)

ATER Aterian
$4.00 /

-0.33 (-7.63%)

ALV Autoliv
$70.57 /

-1.8 (-2.49%)

  • 16
    Nov
  • 18
    Nov
  • 16
    Jun
SWAV ShockWave Medical
$115.98 /

-21.305 (-15.52%)

PTON Peloton
$14.13 /

-1.59 (-10.12%)

PFE Pfizer
$48.68 /

-0.385 (-0.78%)

BHVN Biohaven Pharmaceutical
$83.34 /

-6.81 (-7.55%)

XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

UPST Upstart
$77.01 /

-6.81 (-8.12%)

SWAV ShockWave Medical
$115.98 /

-21.305 (-15.52%)

PTON Peloton
$14.13 /

-1.59 (-10.12%)

PLUG Plug Power
$16.64 /

-2.76 (-14.23%)

PFE Pfizer
$48.68 /

-0.385 (-0.78%)

LPSN LivePerson
$16.27 /

-2.55 (-13.55%)

GDRX GoodRx
$10.75 /

-2.01 (-15.76%)

CLOV Clover Health
$2.42 /

-0.27 (-10.04%)

CARG CarGurus
$29.82 /

-1.89 (-5.96%)

BHVN Biohaven Pharmaceutical
$83.34 /

-6.81 (-7.55%)

ATER Aterian
$4.00 /

-0.33 (-7.63%)

ALV Autoliv
$70.57 /

-1.8 (-2.49%)

XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

UPST Upstart
$77.01 /

-6.81 (-8.12%)

PTON Peloton
$14.13 /

-1.59 (-10.12%)

PLUG Plug Power
$16.64 /

-2.76 (-14.23%)

PFE Pfizer
$48.68 /

-0.385 (-0.78%)

GDRX GoodRx
$10.75 /

-2.01 (-15.76%)

CLOV Clover Health
$2.42 /

-0.27 (-10.04%)

ATER Aterian
$4.00 /

-0.33 (-7.63%)

Hot Stocks
Dentsply Sirona notified SEC of late filing of 10-Q amid internal investigation » 08:45
05/10/22
05/10
08:45
05/10/22
08:45
XRAY

Dentsply Sirona

$39.26 /

-1.335 (-3.29%)

Dentsply Sirona said:…

Dentsply Sirona said: "The company today has filed a Form 12b-25, Notification of Late Filing, with the U.S. Securities and Exchange Commission. As noted in the Form 12b-25, the Audit and Finance Committee of the company's Board of Directors commenced an internal investigation regarding certain financial reporting matters. The investigation is ongoing, and the company cannot predict the duration or outcome of the investigation. As a result, the company has not yet finalized its financial statements or its assessment of the impact of the investigation on its historical financial statements or for the financial statements for the three months ended March 31, 2022, and is therefore unable to file the Form 10-Q on a timely basis."

ShowHide Related Items >><<
XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

04/22/22 H.C. Wainwright
Dentsply Sirona price target lowered to $48 from $58 at H.C. Wainwright
04/20/22 Barrington
Dentsply Sirona price target lowered to $53 from $72 at Barrington
04/19/22 Piper Sandler
Dentsply Sirona downgraded to Neutral from Overweight at Piper Sandler
04/19/22 BofA
BofA downgrades Dentsply Sirona, says 'too much unknown' after pre-announcement
XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

Earnings
Dentsply Sirona now sees FY22 adjusted EPS of $2.35-$2.55, consensus $2.77 » 08:44
05/10/22
05/10
08:44
05/10/22
08:44
XRAY

Dentsply Sirona

$39.26 /

-1.335 (-3.29%)

Now sees FY22 revenue…

Now sees FY22 revenue $4.1B-$4.2B, consensus $4.23B. The company said: "Based on the results of the first quarter and a challenging macroeconomic environment, we are updating our 2022 outlook. The revised outlook for 2022 includes organic sales growth of 2% to 3%, with net sales in the range of $4.1 billion to $4.2 billion. Adjusted operating income margin is expected to be greater than 17% for the full year. Adjusted EPS is estimated to be in the range of $2.35 to $2.55."

ShowHide Related Items >><<
XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

04/22/22 H.C. Wainwright
Dentsply Sirona price target lowered to $48 from $58 at H.C. Wainwright
04/20/22 Barrington
Dentsply Sirona price target lowered to $53 from $72 at Barrington
04/19/22 Piper Sandler
Dentsply Sirona downgraded to Neutral from Overweight at Piper Sandler
04/19/22 BofA
BofA downgrades Dentsply Sirona, says 'too much unknown' after pre-announcement
XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

Earnings
Dentsply Sirona reports Q1 adjusted EPS 52c, consensus 56c » 08:42
05/10/22
05/10
08:42
05/10/22
08:42
XRAY

Dentsply Sirona

$39.26 /

-1.335 (-3.29%)

Reports Q1 revenue $965M,…

Reports Q1 revenue $965M, consensus $988.43M. "The first quarter was a challenging quarter, and our financial performance and revised outlook reflect the impact of larger-than-expected macroeconomic headwinds and lower-than-expected performance in the United States. Despite these challenges, organic growth in Europe was robust, demand remains strong, and our teams are working diligently to reduce lead times to address supply chain challenges. We are confident in our ability to address these transient headwinds and we have high conviction about our future. Dental remains an attractive market. We have a healthy innovation pipeline, leading digital capabilities, and a well-positioned portfolio which will drive sustainable growth long-term," said Interim CEO John Groetelaars.

ShowHide Related Items >><<
XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

04/22/22 H.C. Wainwright
Dentsply Sirona price target lowered to $48 from $58 at H.C. Wainwright
04/20/22 Barrington
Dentsply Sirona price target lowered to $53 from $72 at Barrington
04/19/22 Piper Sandler
Dentsply Sirona downgraded to Neutral from Overweight at Piper Sandler
04/19/22 BofA
BofA downgrades Dentsply Sirona, says 'too much unknown' after pre-announcement
XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

XRAY Dentsply Sirona
$39.26 /

-1.335 (-3.29%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.